Skip to main content

Visit our other sites

jnj.com
jnjinnovation network
Quickfire Challenges

Main navigation

Home
About us
Partner with us
Blog
News
Challenges
Video hub
Connect with Us

News

Maintabs

All news
Press releases
In the media
Partner news
Social
Other News

Article view
List view

Refine by

Refine by

Type

In the media
JNJ Press releases
Other news
(-) Partner news
(-) Press release

Period

2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009

(-) Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec

Locations & regions

EMEA

Focus area

Pharmaceuticals

Clear filters

News

23 January 2020

BlackThorn Therapeutics Advances Phase 2 Clinical Development for Selective KOR Antagonist, BTRX-140, in Neuropsychiatric Disorders

Read full story

13 January 2020

Concerto HealthAI Establishes Real-World Data and AI Collaboration with Janssen

Read full story

13 January 2020

Exonate Announces Collaboration with Janssen to develop a new eye drop for the treatment of retinal vascular diseases including wet age-related macular degeneration (AMD) and diabetic macular oedema (DMO)

Read full story

24 January 2019

Memebox Closes $35 Million Financing to Fuel Innovation and Accelerate Company Growth

Read full story

23 January 2019

Philogen Announces Drug Discovery Collaboration With Johnson & Johnson Innovation

Read full story

Ribon Therapeutics Raises $65 Million to Advance Pipeline of Novel Therapeutics Targeting Cellular Stress Pathways for Cancer

Read full story

E-Scape Bio Appoints Dr. Carrolee Barlow as Chief Medical Officer

Read full story

Carbon Announces JJDC as Additional Investor in $200 Million Funding Round

Read full story

Nuevolution to receive license fee payment of USD 750,000

Read full story

Alligator Bioscience to Receive USD 6 Million Milestone Payment from Janssen Coupled to the Decision to Initiate Combination Trial with ADC-1013

Read full story

26 January 2017

Verb Surgical Delivers Digital Surgery Prototype Demonstration to Collaboration Partners

Read full story

BlackThorn Therapeutics Secures $14 Million in Series A Extension Financing

Read full story

26 January 2016

Inivata Completes £31.5 Million ($45M) Series A Fundraising Round

Read full story

11 January 2016

Aelix Therapeutics Completes Series A Funding of €11.5M ($12.7 M) for Therapeutic HIV Vaccine

Read full story

11 January 2016

CartiHeal Raises $15 Million

Read full story

Load More

Sidebar

Currently trending

Currently trending

Dr. Sadasivan Vidyasagar, Associate Professor at University of Florida, and entrinsic bioscience CEO Stephen Gatto, Receive University of Florida's 'Invention of the Year 2020' Award
XWPharma Announces $40 Million Financing and Appoints Leonard Blum as Chief Executive Officer
ESCAPE Bio Closes $73 Million in Crossover Financing to Advance Clinical Development of Precision Neurology Medicines for Genetic Neurodegeneration
Rodeo Therapeutics Nominates First-in-Class Oral Development Candidate for Inflammatory Bowel Disease
Johnson & Johnson Innovation and BARDA Select a Surge Force of Companies with the Aim to Combat the COVID-19 Pandemic as Part of Its BLUE KNIGHT™ Collaboration
Johnson & Johnson Innovation and Janssen Announce the Awardees of the World Without Disease Call-for-Proposal
GI Windows Raises $16.4M in Series A-1 Financing
Johnson & Johnson to Acquire Momenta Pharmaceuticals, Inc., Expanding Janssen’s Leadership in Novel Treatments for Autoimmune Diseases
ImmPACT Bio USA Inc. Raises $18 Million In Series A Financing
Thirty Madison Raises $47M in Series B Financing From Polaris Partners, Johnson & Johnson Innovation - JJDC, Inc. and Existing Investors

Trending

Trending

Paul Stoffels, M.D., Vice Chair of the Executive Committee and Chief Scientific Officer, Johnson & Johnson, discusses the value of collaboration

Johnson & Johnson Innovation, Change One Thing, Change Everything: Medopad

Johnson & Johnson Innovation, Change One Thing, Change Everything: Exonate